Current Therapy in Reptile Medicine and Surgery 2014
DOI: 10.1016/b978-1-4557-0893-2.00021-1
|View full text |Cite
|
Sign up to set email alerts
|

Infectious Diseases of Amphibians

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…In comparison with our results, different patterns of microbiota restructuring throughout ontogeny or translocation would probably be expected in locations with a higher prevalence of ranaviruses and chytrid fungi. Regardless, note that most of the phylotypes identified within our samples remained untested against Bd (74% at D0 and 70% in control samples at D15), and that no database was available to test their activity against the many other pathogens that threaten amphibians (Pessier, 2014) and induce changes in their skin microbial communities (Federici et al, 2015; Harrison et al, 2019). Moreover, the production and function of microbial secondary metabolites can differ among pathogen isolates (Antwis & Harrison, 2018), so 16S sequencing is not sufficient to ascertain the antifungal properties of the identified phylotypes.…”
Section: Discussionmentioning
confidence: 99%
“…In comparison with our results, different patterns of microbiota restructuring throughout ontogeny or translocation would probably be expected in locations with a higher prevalence of ranaviruses and chytrid fungi. Regardless, note that most of the phylotypes identified within our samples remained untested against Bd (74% at D0 and 70% in control samples at D15), and that no database was available to test their activity against the many other pathogens that threaten amphibians (Pessier, 2014) and induce changes in their skin microbial communities (Federici et al, 2015; Harrison et al, 2019). Moreover, the production and function of microbial secondary metabolites can differ among pathogen isolates (Antwis & Harrison, 2018), so 16S sequencing is not sufficient to ascertain the antifungal properties of the identified phylotypes.…”
Section: Discussionmentioning
confidence: 99%